Marshall Islands vs New Zealand: Coverage of the human papillomavirus vaccine
Marshall Islands
49
in 2025
New Zealand
52
in 2025
Marshall Islands rank
64th
New Zealand rank
61st
Coverage of the human papillomavirus vaccine over time
- Marshall Islands
- New Zealand
How they compare
New Zealand currently reports 52 against 49 in Marshall Islands, a difference of 3.
That makes New Zealand's figure about 1.1 times Marshall Islands's.
Across all 13 years both countries report, New Zealand has been ahead every year.
Marshall Islands ranks 64th and New Zealand ranks 61st of 85 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Marshall Islands | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 21.43 | 54.71 | 33.29 | New Zealand |
| 2020s | 49.5 | 62.17 | 12.67 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Marshall Islands or New Zealand?
- New Zealand, at 52 against 49 in Marshall Islands as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Marshall Islands and New Zealand?
- 3, with New Zealand ahead.
- How many years of comparable data are there for Marshall Islands and New Zealand?
- 13 years are reported by both, from 2013 to 2025.
- How do Marshall Islands and New Zealand rank globally for coverage of the human papillomavirus vaccine?
- Marshall Islands ranks 64th and New Zealand ranks 61st of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.